Biological bank for patients with autoimmune cytopenia
Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia
University Hospital, Bordeaux · NCT04005638
This study is setting up a collection of biological samples from patients with autoimmune cytopenia to help researchers learn more about these conditions and find better treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Bordeaux (other) |
| Locations | 1 site (Pessac) |
| Trial ID | NCT04005638 on ClinicalTrials.gov |
What this trial studies
This observational study aims to establish a biological bank for patients diagnosed with autoimmune cytopenia, including immune thrombocytopenia, autoimmune hemolytic anemia, and autoimmune neutropenia. The research is conducted by the Internal Medicine Department of Haut-Lévêque Hospital, which has been recognized as a reference center for these conditions. The biological samples collected will support translational and fundamental research, facilitating collaboration between clinical departments and research units to explore the underlying mechanisms of these disorders and develop new treatment options.
Who should consider this trial
Good fit: Ideal candidates for this study are patients over 16 years old diagnosed with autoimmune cytopenia who can provide informed consent.
Not a fit: Patients who are currently undergoing treatment for autoimmune cytopenia or those with viral infections such as HIV or Hepatitis will not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could lead to advancements in understanding and treating autoimmune cytopenias, ultimately improving patient outcomes.
How similar studies have performed: While this approach is not entirely novel, similar studies have shown promise in utilizing biological banks for advancing research in autoimmune diseases.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 16 years old. * Patients with autoimmune cytopenia according to the definitions reported in the latest update of the French National Care Protocol (PNDS 2017). * Affiliated person or beneficiary of a social security scheme. * Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research). Exclusion Criteria: * Positivity for HIV, Hepatitis C or B virus. * Pregnant or lactating woman. * Patient undergoing treatment for autoimmune cytopenia
Where this trial is running
Pessac
- CHU de Bordeaux - service de médecine interne — Pessac, France (RECRUITING)
Study contacts
- Principal investigator: Jean-François VIALLARD, Prof — University Hospital, Bordeaux
- Study coordinator: Jean-François VIALLARD, Prof
- Email: jean-françois.viallard@chu-bordeaux.fr
- Phone: 05.57.65.64.83
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Autoimmune Neutropenia, Biological collection